Depreciation of iBio, Inc. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
iBio, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • iBio, Inc. Depreciation for the quarter ending 30 Sep 2025 was $123,000, a 2.5% increase year-over-year.
  • iBio, Inc. annual Depreciation for 2025 was $484,000, a 24% decline from 2024.
  • iBio, Inc. annual Depreciation for 2024 was $638,000, a 5.3% decline from 2023.
  • iBio, Inc. annual Depreciation for 2023 was $674,000, a 70% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

iBio, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $123,000 +$3,000 +2.5% 01 Jul 2025 30 Sep 2025 10-Q/A 17 Nov 2025 2026 Q1
Q3 2024 $120,000 -$45,000 -27% 01 Jul 2024 30 Sep 2024 10-Q/A 17 Nov 2025 2026 Q1
Q3 2023 $165,000 -$106,000 -39% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2025 Q1
Q3 2022 $2,240,000 $271,000 -$35,000 -11% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 $2,275,000 $743,000 +$601,000 +423% 01 Apr 2022 30 Jun 2022 10-K 27 Sep 2023 2023 FY
Q1 2022 $1,674,000 $709,000 +$590,000 +496% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2022 2022 Q3
Q4 2021 $1,084,000 $517,000 +$403,000 +354% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 $681,000 $306,000 +$209,000 +215% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q2 2021 $472,000 $142,000 +$67,000 +89% 01 Apr 2021 30 Jun 2021 10-K 11 Oct 2022 2022 FY
Q1 2021 $405,000 $119,000 +$49,000 +70% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q3
Q4 2020 $356,000 $114,000 +$43,000 +61% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q2
Q3 2020 $313,000 $97,000 +$31,000 +47% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q1
Q2 2020 $282,000 $75,000 -$287,000 -79% 01 Apr 2020 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 $569,000 $70,000 -$271,000 -79% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q3
Q4 2019 $840,000 $71,000 -$293,000 -80% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q2
Q3 2019 $1,133,000 $66,000 -$294,000 -82% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2021 Q1
Q2 2019 $1,427,000 $362,000 +$340,673,000 01 Apr 2019 30 Jun 2019 10-K 13 Oct 2020 2020 FY
Q1 2019 $339,246,000 $341,000 -$340,659,000 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q3
Q4 2018 $1,413,000 $364,000 +$23,000 +6.7% 01 Oct 2018 31 Dec 2018 10-Q 13 Feb 2019 2019 Q2
Q3 2018 $1,390,000 $360,000 +$22,000 +6.5% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2020 Q1
Q2 2018 $1,368,000 $340,311,000 -$340,650,000 -100487% 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2019 2019 FY
Q1 2018 $342,018,000 $341,000,000* +$340,663,000 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q3
Q4 2017 $1,355,000 $341,000 +$15,000 +4.6% 01 Oct 2017 31 Dec 2017 10-Q 13 Feb 2019 2019 Q2
Q3 2017 $1,340,000 $338,000 +$14,000 +4.3% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q2 2017 $1,326,000 $339,000 +$287,000 +552% 01 Apr 2017 30 Jun 2017 10-K 18 Sep 2018 2018 FY
Q1 2017 $1,039,000 $337,000 +$76,000 +29% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q3
Q4 2016 $963,000 $326,000 +$63,000 +24% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018 2018 Q2
Q3 2016 $900,000 $324,000 +$323,000 +32300% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $577,000 $52,000 01 Apr 2016 30 Jun 2016 10-K 15 Sep 2017 2017 FY
Q1 2016 $261,000 +$250,000 +2273% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q3
Q4 2015 $263,000 01 Jan 2016 31 Jan 2016 10-Q 23 May 2016 2016 Q3
Q4 2015 $1,000 01 Oct 2015 31 Dec 2015 10-Q 21 Feb 2017 2017 Q2
Q3 2015 $1,000 $0 0% 01 Jul 2015 30 Sep 2015 10-Q 18 Nov 2016 2017 Q1
Q1 2015 $11,000 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q3
Q3 2014 $1,000 $0 0% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2016 Q1
Q3 2013 $1,000 +$1,000 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2015 Q1
Q3 2012 $0 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2014 Q1

iBio, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $484,000 -$154,000 -24% 01 Jul 2024 30 Jun 2025 10-K 05 Sep 2025 2025 FY
2024 $638,000 -$36,000 -5.3% 01 Jul 2023 30 Jun 2024 10-K 05 Sep 2025 2025 FY
2023 $674,000 -$1,601,000 -70% 01 Jul 2022 30 Jun 2023 10-K/A 24 Sep 2024 2024 FY
2022 $2,275,000 +$1,803,000 +382% 01 Jul 2021 30 Jun 2022 10-K 27 Sep 2023 2023 FY
2021 $472,000 +$190,000 +67% 01 Jul 2020 30 Jun 2021 10-K 11 Oct 2022 2022 FY
2020 $282,000 -$1,145,000 -80% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021 2021 FY
2019 $1,427,000 +$59,000 +4.3% 01 Jul 2018 30 Jun 2019 10-K 13 Oct 2020 2020 FY
2018 $1,368,000 +$42,000 +3.2% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2019 2019 FY
2017 $1,326,000 +$749,000 +130% 01 Jul 2016 30 Jun 2017 10-K 18 Sep 2018 2018 FY
2016 $577,000 +$572,000 +11440% 01 Jul 2015 30 Jun 2016 10-K 15 Sep 2017 2017 FY
2015 $5,000 +$2,000 +67% 01 Jul 2014 30 Jun 2015 10-K 13 Oct 2016 2016 FY
2014 $3,000 +$1,000 +50% 01 Jul 2013 30 Jun 2014 10-K 13 Oct 2015 2015 FY
2013 $2,000 -$5,000 -71% 01 Jul 2012 30 Jun 2013 10-K 29 Sep 2014 2014 FY
2012 $7,000 01 Jul 2011 30 Jun 2012 10-K/A 04 Oct 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.